Ranbaxy Laboratories may run upto Rs 450-455

39364 Investors following Cipla. Share this News with them.

0

Like this story, share it with millions of investors on M3

Ranbaxy Laboratories may run upto Rs 450-455

Technical Analyst, Ashwani Gujral is of the view that Ranbaxy Laboratories may run upto Rs 450-455, if there is some good news.

Post your opinion here

 

0

Tweet

Share on Tumblr

Excerpts from Your Stocks on CNBC-TV18 Watch the full show » ALSO READ See what other Experts & Brokerages are saying about Cipla See messages about Cipla Cipla BSE | NSE 28/05/12 Are Mutual Funds betting on Cipla? Other Stocks in this news Dr Reddys Laboratories | Glenmark Pharma | Ranbaxy Laboratories |

Technical Analyst, Ashwani Gujral is of the view that Ranbaxy Laboratories may run upto Rs 450-455, if there is some good news.

Gujral told CNBC-TV18, "Ranbaxy Laboratories seems to be finding support at lower levels around Rs 400-405, if there is some good news it may run-up to Rs 450-455."

He further added, "We have seen Dr Reddys Labs tends to fail above Rs 800-820. Cipla has been a range bound for a long-time also Glenmark seems to be headed to about Rs 750. I do not think the largecap pharmaceutical is showing a lot of traction."